253 related articles for article (PubMed ID: 30893570)
1. Metformin use in hidradenitis suppurativa.
Jennings L; Hambly R; Hughes R; Moriarty B; Kirby B
J Dermatolog Treat; 2020 May; 31(3):261-263. PubMed ID: 30893570
[No Abstract] [Full Text] [Related]
2. Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa.
Moussa C; Wadowski L; Price H; Mirea L; O'Haver J
J Drugs Dermatol; 2020 Dec; 19(12):1231-1234. PubMed ID: 33346525
[TBL] [Abstract][Full Text] [Related]
3. Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators.
Hambly R; Kearney N; Hughes R; Fletcher JM; Kirby B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108132
[TBL] [Abstract][Full Text] [Related]
4. Metformin for the treatment of hidradenitis suppurativa: a little help along the way.
Verdolini R; Clayton N; Smith A; Alwash N; Mannello B
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1101-8. PubMed ID: 22882365
[TBL] [Abstract][Full Text] [Related]
5. Long-standing hidradenitis suppurativa treated effectively with metformin.
Arun B; Loffeld A
Clin Exp Dermatol; 2009 Dec; 34(8):920-1. PubMed ID: 19323659
[No Abstract] [Full Text] [Related]
6. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
7. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
[TBL] [Abstract][Full Text] [Related]
9. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
[TBL] [Abstract][Full Text] [Related]
10. The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide.
Jennings L; Nestor L; Molloy O; Hughes R; Moriarty B; Kirby B
Br J Dermatol; 2017 Sep; 177(3):858-859. PubMed ID: 27943236
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
Rosi E; Pescitelli L; Ricceri F; Di Cesare A; Novelli A; Pimpinelli N; Prignano F
Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
[TBL] [Abstract][Full Text] [Related]
12. Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa.
Golbari NM; Porter ML; Kimball AB
J Am Acad Dermatol; 2019 Jan; 80(1):114-119. PubMed ID: 30003993
[TBL] [Abstract][Full Text] [Related]
13. Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial.
Vossen ARJV; van Doorn MBA; van der Zee HH; Prens EP
J Am Acad Dermatol; 2019 Jan; 80(1):80-88. PubMed ID: 30482392
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
Scheinfeld N
Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
[TBL] [Abstract][Full Text] [Related]
16. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
[TBL] [Abstract][Full Text] [Related]
17. Infliximab for the treatment of hidradenitis suppurativa.
Fernández-Vozmediano JM; Armario-Hita JC
Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
[TBL] [Abstract][Full Text] [Related]
18. The Role of Androgens and Estrogens in Hidradenitis Suppurativa - A Systematic Review.
Riis PT; Ring HC; Themstrup L; Jemec GB
Acta Dermatovenerol Croat; 2016 Dec; 24(4):239-249. PubMed ID: 28128074
[TBL] [Abstract][Full Text] [Related]
19. Infliximab for hidradenitis suppurativa.
Sullivan TP; Welsh E; Kerdel FA; Burdick AE; Kirsner RS
Br J Dermatol; 2003 Nov; 149(5):1046-9. PubMed ID: 14632813
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
